-
-
-
-
-
-
-
Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023
-
-
-
-
-
-
-
Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer
-
-
-
-
-
-
-
Seres Therapeutics Announces Appointment of Thomas J. DesRosier as Chief Legal Officer and Executive Vice President
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

